https://sputnikglobe.com/20210701/russias-sputnik-v-vaccine-effective-against-argentine-covid-19-strains-scientists-say-1083280427.html
Russia's Sputnik V Vaccine Effective Against Argentine COVID-19 Strains, Scientists Say
Russia's Sputnik V Vaccine Effective Against Argentine COVID-19 Strains, Scientists Say
Sputnik International
BUENOS AIRES (Sputnik) - A study by Argentine scientists showed that the use of the Russian Sputnik V vaccine causes the production of antibodies against the... 01.07.2021, Sputnik International
2021-07-01T06:15+0000
2021-07-01T06:15+0000
2021-07-01T06:15+0000
world
newsfeed
sputnik v vaccine
vaccine
argentina
https://cdn1.img.sputnikglobe.com/img/07e5/05/09/1082841328_0:141:3141:1907_1920x0_80_0_0_5efa5e2271812813545254c55ab15e01.jpg
"There was no difficulty in the neutralizing activity of sera from people vaccinated with Sputnik V," according to the findings of the study by Proyecto PAIS, the Biobank of Infectious Diseases (BBEI), the Inbris Institute and the Jose de San Martin hospital.The researchers noted that the immunized individuals developed antibodies that neutralize the SARS-CoV-2 variants that circulate in Argentina: lines P.1 (gamma), B.1.1.7 (alpha) and C.37 (lambda).At the same time, the amount of antibodies neutralizing the gamma variant in the blood sera of convalescent patients or those vaccinated with Sputnik was reduced by 67 percent.Sputnik V, developed by the Russian Gamaleya research institute, was the world’s first registered vaccine against COVID-19.
argentina
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
newsfeed, sputnik v vaccine, vaccine, argentina
newsfeed, sputnik v vaccine, vaccine, argentina
Russia's Sputnik V Vaccine Effective Against Argentine COVID-19 Strains, Scientists Say
BUENOS AIRES (Sputnik) - A study by Argentine scientists showed that the use of the Russian Sputnik V vaccine causes the production of antibodies against the gamma (Brazil), alpha (UK) and lambda (the Andes, South America) variants, which are common in Argentina.
"There was no difficulty in the neutralizing activity of sera from people
vaccinated with Sputnik V," according to the findings of the study by Proyecto PAIS, the Biobank of Infectious Diseases (BBEI), the Inbris Institute and the Jose de San Martin hospital.
The researchers noted that the immunized individuals developed antibodies that neutralize the SARS-CoV-2 variants that circulate in Argentina: lines P.1 (gamma), B.1.1.7 (alpha) and C.37 (lambda).
At the same time, the amount of antibodies neutralizing the gamma variant in the blood sera of convalescent patients or those vaccinated with Sputnik was reduced by 67 percent.
Sputnik V, developed by the Russian Gamaleya research institute, was the world’s first registered vaccine against COVID-19.
